- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Sensitizing EGFR Mutations
Total 2622 results
-
Universität Duisburg-EssenTerminatedNon-small-cell Lung Cancer With Somatic EGFR Mutations
-
Incyte CorporationWithdrawnSolid Tumors and Hematologic Malignancy | NSCLC (Non-small Cell Lung Carcinoma)United States
-
Hospital Erasto GaertnerAstraZenecaCompletedLung Neoplasms | KRAS Gene Mutation | EGFR Gene MutationBrazil
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC)United States, Australia, Belgium, Canada, Chile, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Peru, Portugal, Romania, Russian Federation, Singapore, Spain, Taiwan, Thailand, Ukraine, United Kingdom
-
Astellas Pharma IncCompletedNSCLC | Non Small Cell Lung CancerUnited States, Canada, Korea, Republic of, Singapore, Thailand, Hong Kong
-
Yonsei UniversityUnknownCompletely Resected NSCLC With Common EGFR MutationsKorea, Republic of
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.CompletedNon-small Cell Lung CancerUnited States
-
Astellas Pharma IncTerminatedEGFR-TKI-naïve Patients With NSCLC Harboring EGFR Activating MutationsJapan
-
National University Hospital, SingaporeAstraZeneca; Singapore Clinical Research InstituteUnknownCarcinoma, Non-Small-Cell LungTaiwan, Hong Kong, Thailand, Singapore, Korea, Republic of
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerHong Kong, Korea, Republic of, Taiwan, Thailand
-
Guangdong Association of Clinical TrialsZhejiang Cancer Hospital; Peking University People's Hospital; Sun Yat-sen University and other collaboratorsUnknownNon-small Cell Lung CancerChina
-
Astellas Pharma Global Development, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor (EGFR) MutationsUnited States
-
Hebei Medical University Fourth HospitalUnknown
-
Guangdong Association of Clinical TrialsUnknown
-
Sun Yat-sen UniversityUnknown
-
Massachusetts General HospitalCompletedNon Small Cell Lung CancerUnited States
-
First People's Hospital of HangzhouCompletedNon-small Cell Lung Cancer Stage III | Non-Small-Cell Lung Cancer MetastaticChina
-
Massachusetts General HospitalBoehringer Ingelheim; University of TexasCompletedNon-small Cell Lung Cancer | EGFR MutationsUnited States
-
First People's Hospital of HangzhouCompletedNon-small Cell Lung Cancer Stage III | Non-Small-Cell Lung Cancer MetastaticChina
-
David M. Jackman, MDMassachusetts General Hospital; AstraZenecaCompletedNon-Small Cell Lung CancerUnited States
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.CompletedLung Cancer | Non Small Cell Lung CancerUnited States
-
AIO-Studien-gGmbHBoehringer IngelheimTerminatedNon-small-cell Lung Cancer With Somatic EGFR MutationsGermany
-
Betta Pharmaceuticals Co., Ltd.UnknownPlasma EGFR Mutation-positive Lung CancerChina
-
Association des Gastroentérologues OncologuesPitié-Salpêtrière Hospital; Hôpital Européen George Pompidou, APHP, Paris,... and other collaboratorsUnknownMetastatic Colorectal Cancer
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerSpain
-
Astellas Pharma Global Development, Inc.WithdrawnSolid Tumors | Epidermal Growth Factor Receptor (EGFR) Mutations
-
Astellas Pharma Global Development, Inc.WithdrawnSubjects With NSCLC With an EGFR Activating Mutation
-
AstraZenecaCompletedEGFR Mutation Status in aNSCLC PatientsKorea, Republic of, Russian Federation, Malaysia, China, Australia, Taiwan, Thailand, Indonesia, Singapore
-
Spanish Lung Cancer GroupCompletedNon Small Cell Lung CancerSpain
-
Hoffmann-La RocheCompleted
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungCanada
-
Guangdong Provincial People's HospitalUnknownNon-small Cell Lung Cancer | Epidermal Growth Factor ReceptorChina
-
Chinese Society of Lung CancerGuangdong Provincial People's HospitalCompleted
-
AstraZenecaCompletedCaucasian Patients With EGFR Mutation Positive Advanced NSCLCBulgaria, Italy, Poland, Spain, Turkey, United Kingdom, Romania, Norway, Hungary, Portugal, Greece, Switzerland, France
-
Shanghai Chest HospitalChanghai Hospital; Ruijin HospitalUnknown
-
First People's Hospital of HangzhouUnknownNon-small Cell Lung Cancer Stage III | Adenocarcinoma of Lung | Non-Small-Cell Lung Cancer Metastatic | EGFR WildtypeChina
-
Massachusetts General HospitalM.D. Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; Dana-Farber...CompletedNon Small Cell Lung CancerUnited States
-
AstraZenecaCompletedEGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.Italy, Spain, United Kingdom, Sweden, Japan, Netherlands, Germany, France
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungUnited States, Taiwan
-
AstraZenecaNo longer available
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerJordan
-
Zhejiang Cancer HospitalUnknownNon-small Cell Lung Cancer | Aquired Resistance | EGFR TKIsChina
-
Peking Union Medical College HospitalUnknownNon-small Cell Lung Cancer | Leptomeningeal MetastasisChina
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerHungary, Latvia, Turkey
-
AstraZenecaCompletedNon Small Cell Lung CancerGreece
-
Memorial Sloan Kettering Cancer CenterAscenta TherapeuticsTerminated
-
M.D. Anderson Cancer CenterCompleted
-
M.D. Anderson Cancer CenterCompleted
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerFinland
-
Zhejiang UniversityBeta Pharma, Inc.; Jiangsu Simcere Pharmaceutical Co., Ltd.Unknown